论文部分内容阅读
目的:探讨分析床边间歇性血液透析(IHD)在老年重症肾衰竭患者中的临床价值。方法:选择于2011年5月～2012年8月在我院行住院治疗的重症肾衰竭患者37例,给予床边间歇性血液透析治疗,比较治疗前后患者在血清肌酐(Scr)、尿素氮(BUN)、内生肌酐清除率(Ccr)方面的改善情况。结果:治疗后发现患者在血清肌酐(Scr)、尿素氮(BUN)、内生肌酐清除率(Ccr)方面较治疗前都得到显著改善,差异显著(P<0.05),具有统计学意义。同时随访调查发现患者的1年存活率为67.6%,高于老年重症肾衰竭患者1年平均存活率(51.4%);结论:床边间歇性血液透析在老年重症肾衰竭患者中具有较高的临床价值,疗效好、患者存活率高,值得在临床治疗中推广应用。
Objective: To investigate the clinical value of bedside intermittent hemodialysis (IHD) in elderly patients with severe renal failure. Methods: Thirty-seven patients with severe renal failure hospitalized in our hospital from May 2011 to August 2012 were enrolled in this study. Interventional bedside hemodialysis was performed. The serum creatinine (Scr), blood urea nitrogen BUN), endogenous creatinine clearance (Ccr) aspects of the improvement. Results: After treatment, the patients’ serum creatinine (Scr), blood urea nitrogen (BUN) and endogenous creatinine clearance (Ccr) were significantly improved compared with those before treatment, with significant difference (P <0.05). At the same time follow-up survey found that patients with 1-year survival rate was 67.6%, higher than the elderly patients with severe renal failure 1-year average survival rate (51.4%); Conclusion: Bedside intermittent hemodialysis in elderly patients with severe renal failure have a higher Clinical value, good effect, high survival rate, it is worth in the clinical treatment of the promotion and application.